DOCSLIB.ORG

Biological, Chemical and Information for Clinicians Radiological Terrorism

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Biological, Chemical and Information for Clinicians Radiological Terrorism ZEBRA PACKET 2010 Biological, Chemical and Radiological Terrorism Information for Clinicians County of San Diego Public Health Services Emergency Medical Services COUNTY OF SAN DIEGO HEALTH AND HUMAN SERVICES AGENCY PUBLIC HEALTH SERVICES EMERGENCY MEDICAL SERVICES BIOLOGICAL, CHEMICAL & RADIOLOGICAL TERRORISM INFORMATION FOR CLINICIANS ZEBRA PACKET September 2010 This document is funded by a Federal Centers for Disease Control and Prevention (CDC) grant for the Cities Readiness Initiative Program. The grant funding was awarded to the County of San Diego by the State of California. COUNTY OF SAN DIEGO HEALTH AND HUMAN SERVICES AGENCY PUBLIC HEALTH SERVICES EMERGENCY MEDICAL SERVICES ZEBRA PACKET Adapted by the County of San Diego Division of Emergency Medical Services from the Santa Clara County Public Health Department of the same title. ACKNOWLEDGMENTS County of Los Angeles Public Health, Emergency Medical Services Agency County of San Diego Epidemiology & Immunization Services Branch County of San Diego Department of Environmental Health County of San Diego Office of Emergency Services County of San Diego Operational Area Metropolitan Medical Strike Team County of San Diego Public Health Laboratory San Diego County Medical Society UCSD Medical Center Additional Acknowledgement: Catherine L. Blaser, R.N., EMS Summer/Fall 2010 Intern, Project Research COUNTY OF SAN DIEGO HEALTH AND HUMAN SERVICES AGENCY PUBLIC HEALTH SERVICES EMERGENCY MEDICAL SERVICES Table of Contents Introduction Acknowledgements Table of Contents Reporting Disease Reporting Confidential Morbidity Report Detecting Bioterrorism: The Clinicians Role Reporting Suspected Bioterrorism Related Illness Health Alert Network and Volunteer Medical Professionals California Health Alert Network (CAHAN) California Disaster Healthcare Volunteers (DHV) Biological Agents Ten Critical Steps for Handling Possible Bioterrorism Events Isolation Guidelines Bioterrorism Overview Category A Anthrax Anthrax Bioterrorism: Lessons Learned and Future Directions Smallpox Evaluating Patients for Smallpox Worksheet Diagnosis and Management of Smallpox Plague Botulism Tularemia Viral Hemorrhagic Fever Chemical Agents Overview Article Chemical Terrorism Information and Treatment Guidelines for Hospitals and Clinicians Biotoxins Vesicant Agents Blood Agents Pulmonary Agents September 2010 Incapacitating Agents Nerve Agents Riot Control Agents Nuclear/Radiological Emergencies Overview Article Nuclear/Radiological Terrorism Information and Treatment Guidelines for Hospitals and Clinicians Radiation Information Patient KI Pre-screening Questionnaire Mass Casualty Events Explosions and Blast Injuries Blast Injury Essential Facts Lung Injury Crush Injuries Abdominal Injury Extremity Injury Eye Injury Thermal Injury Mental Health Issues References September 2010 County of San Diego, Office of Public Health Physicians and health care providers must report the following conditions. Suspected, lab-confirmed, and/or clinical diagnoses are reportable within specified time intervals. Reporting enables appropriate public health interventions. PHONE PHONE 619-515-6620 619-515-6620 or after 5:00 P.M. FAX 619-515-6644 858-565-5255 IMMEDIATELY: ONE WORKING DAY: Anthrax Amebiasis Psittacosis Botulism Anisakiasis Poliomyelitis Brucellosis* Babesiosis Q Fever Cholera Campylobacteriosis Relapsing Fever Dengue Colorado Tick Fever RMSF Diphtheria Cryptosporidiosis Salmonellosis E-coli O157 Infection Encephalitis (infectious) Shigellosis Hantavirus infections Ehrlichiosis Streptococcal Infections Hemolytic Uremic Syndrome Haemophilus influenzae (invasive) Food Handlers and Measles Hepatitis A Dairy workers only Meningococcal Infections Listeriosis Syphilis Plague (any form) Lymphocytic choriomeningitis Swimmer’s itch Rabies (any form) Malaria Trichinosis Seafood poisoning Meningitis Typhoid Domoic Acid Neonatal conjunctivitis Typus Fever Ciguatera Pertussis Tuberculosis Scrombroid Any food-or-water-borne illness Vibrio infections Paralytic shellfish Yersiniosis Tularemia* Viral Hemorrhagic Fevers Yellow Fever Outbreaks of any disease Outbreak of Neonatal diarrhea Unusual disease occurrence PHONE, FAX, OR MAIL WITHIN ONE WEEK: AIDS Hepatitis, other viral PID Aspergillosis Invasive Group A Streptococcus Reye’s syndrome Chancroid Kawasaki’s syndrome Rheumatic fever, acute Chlamydial infections Legionellosis Rubella Coccidioidomycosis Leprosy Rubella syndrome, congenital Cysticercosis Leptospirosis Tetanus Echinococcosis Lyme Disease Toxic shock syndrome Giardiasis MRSA Toxoplasmosis Gonococcal infections Mumps VRE Hepatitis B,C, D NGU Monday - Friday 8 AM to 5 PM, call County of San Diego, Office of Public Health TEL (619) 515-6620 FAX (619)515-6644 1700 Pacific Highway, Room 107, San Diego, CA 92101 *Not reportable immediately in current regulations, however, because Brucellosis and Tularemia may be used as possible bioterrorism agents, immediate reporting is requested if these conditions are suspected. State of California—Health and Human Services Agency California Department of Public Health CONFIDENTIAL MORBIDITY REPORT NOTE: For STD, Hepatitis, or TB, complete appropriate section below. Special reporting requirements and reportable diseases on back. DISEASE BEING REPORTED: ___________________________________________________________________________________ Patient’s Last Name Social Security Number Ethnicity (✓ one) – – ❒ Hispanic/Latino ❒ Non-Hispanic/Non-Latino Birth Date First Name/Middle Name (or initial) Month Day Year Age Race (✓ one) ❒ African-American/Black ❒ Asian/Pacific Islander (✓ one): Address: Number, Street Apt./Unit Number ❒ Asian-Indian ❒ Japanese ❒ Cambodian ❒ Korean City/Town State ZIP Code ❒ Chinese ❒ Laotian ❒ Filipino ❒ Samoan ❒ ❒ Estimated Delivery Date Guamanian Vietnamese Area Code Home Telephone Gender Pregnant? Month Day Year ❒ Hawaiian – – M F Y N Unk ❒ Other:________________________ ❒ Area Code Work Telephone Patient’s Occupation/Setting Native American/Alaskan Native ❒ Food service ❒ Day care ❒ Correctional facility ❒ White: __________________________ – – ❒ Health care ❒ School ❒ Other _________________________ ❒ Other: __________________________ DATE OF ONSET Reporting Health Care Provider REPORT TO Month Day Year Reporting Health Care Facility DATE DIAGNOSED Address Month Day Year City State ZIP Code DATE OF DEATH Telephone Number Fax Month Day Year ( ) ( ) Submitted by Date Submitted (Month/Day/Year) (Obtain additional forms from your local health department.) SEXUALLY TRANSMITTED DISEASES (STD) VIRAL HEPATITIS Not Syphilis Syphilis Test Results Pos Neg Pend Done ❒ ❒ Primary (lesion present) ❒ Late latent > 1 year ❒ RPR Titer:__________ Hep A anti-HAV IgM ❒ ❒ ❒ ❒ ❒ Secondary ❒ Late (tertiary) ❒ VDRL Titer:__________ ❒ Hep B HBsAg ❒ ❒ ❒ ❒ ❒ Early latent < 1 year ❒ Congenital ❒ FTA/MHA: ❒ Pos ❒ Neg ❒ Acute anti-HBc ❒ ❒ ❒ ❒ ❒ Latent (unknown duration) ❒ CSF-VDRL: ❒ Pos ❒ Neg ❒ Chronic anti-HBc IgM ❒ ❒ ❒ ❒ ❒ Neurosyphilis ❒ Other:_________________ anti-HBs ❒ ❒ ❒ ❒ Gonorrhea Chlamydia ❒ ❒ Hep C anti-HCV ❒ ❒ ❒ ❒ ❒ PID (Unknown Etiology) Urethral/Cervical ❒ Urethral/Cervical ❒ ❒ Acute PCR-HCV ❒ ❒ ❒ ❒ ❒ ❒ Chancroid PID PID ❒ ❒ Chronic ❒ ❒ Non-Gonococcal Urethritis Other: ____________________ Other: _____________ ❒ Hep D (Delta) anti-Delta ❒ ❒ ❒ ❒ STD TREATMENT INFORMATION ❒ Untreated ❒ Other: ______________ ❒ ❒ ❒ ❒ ❒ ❒ Treated (Drugs, Dosage, Route): Date Treatment Initiated Will treat Suspected Exposure Type ❒ ____________________________ Month Day Year Unable to contact patient ❒ Blood ❒ Other needle ❒ Sexual ❒ Household ❒ Refused treatment transfusion exposure contact contact ____________________________ ❒ Referred to: _________________ ❒ Child care ❒ Other: ________________________________ TUBERCULOSIS (TB) TB TREATMENT INFORMATION Status Mantoux TB Skin Test Bacteriology ❒ Current Treatment ❒ Active Disease Month Day Year Month Day Year ❒ INH ❒ RIF ❒ PZA ❒ Confirmed ❒ EMB ❒ Other: ____________ ❒ Suspected Date Performed Date Specimen Collected Month Day Year ❒ Infected, No Disease ❒ Pending Date Treatment ❒ Convertor Results:______________ mm ❒ Not Done Source _______________________________________ Initiated ❒ Reactor Smear: ❒ Pos ❒ Neg ❒ Pending ❒ Not done Chest X-Ray Month Day Year Culture: ❒ Pos ❒ Neg ❒ Pending ❒ Not done ❒ Untreated Site(s) ❒ Will treat BCG Vaccine Given? Yes No ❒ Pulmonary Date Performed ❒ Unable to contact patient If yes, at what age/year? ___________________ ❒ Extra-Pulmonary ❒ Normal ❒ Pending ❒ Not done ❒ Refused treatment ❒ Both ❒ Cavitary ❒ Abnormal/Noncavitary Other test(s) ___________________________________ ❒ Referred to: _____________________ REMARKS PM 110 12/08/2009 (EPI 03/05/2010) State of California - Health and Human Sevices Agency Department of Public Health Title 17, California Code of Regulations (CCR) §2500, §2593, §2641.5-2643.20, and §2800-2812 Reportable Diseases and Conditions* § 2500. REPORTING TO THE LOCAL HEALTH AUTHORITY. ● § 2500(b) It shall be the duty of every health care provider, knowing of or in attendance on a case or suspected case of any of the diseases or condition listed below, to report to the local health officer for the juridiction where the patient resides. Where no health care provider is in attendance, any individual having knowledge of a person who is suspected to be suffering from one of the diseases or conditions listed below may make such a report to the local health officer for the jurisdiction where the patient resides. ● § 2500(c) The administrator of each health facility, clinic, or other setting
Load more

Recommended publications
  • Critical Evaluation of Proven Chemical Weapon Destruction Technologies
    Pure Appl. Chem., Vol. 74, No. 2, pp. 187–316, 2002. © 2002 IUPAC INTERNATIONAL UNION OF PURE AND APPLIED CHEMISTRY ORGANIC AND BIOMOLECULAR CHEMISTRY DIVISION IUPAC COMMITTEE ON CHEMICAL WEAPON DESTRUCTION TECHNOLOGIES* WORKING PARTY ON EVALUATION OF CHEMICAL WEAPON DESTRUCTION TECHNOLOGIES** CRITICAL EVALUATION OF PROVEN CHEMICAL WEAPON DESTRUCTION TECHNOLOGIES (IUPAC Technical Report) Prepared for publication by GRAHAM S. PEARSON1,‡ AND RICHARD S. MAGEE2 1Department of Peace Studies, University of Bradford, Bradford, West Yorkshire BD7 1DP, UK 2Carmagen Engineering, Inc., 4 West Main Street, Rockaway, NJ 07866, USA *Membership of the IUPAC Committee is: Chairman: Joseph F. Burnett; Members: Wataru Ando (Japan), Irina P. Beletskaya (Russia), Hongmei Deng (China), H. Dupont Durst (USA), Daniel Froment (France), Ralph Leslie (Australia), Ronald G. Manley (UK), Blaine C. McKusick (USA), Marian M. Mikolajczyk (Poland), Giorgio Modena (Italy), Walter Mulbry (USA), Graham S. Pearson (UK), Kurt Schaffner (Germany). **Membership of the Working Group was as follows: Chairman: Graham S. Pearson (UK); Members: Richard S. Magee (USA), Herbert de Bisschop (Belgium). The Working Group wishes to acknowledge the contributions made by the following, although the conclusions and contents of the Technical Report remain the responsibility of the Working Group: Joseph F. Bunnett (USA), Charles Baronian (USA), Ron G. Manley (OPCW), Georgio Modena (Italy), G. P. Moss (UK), George W. Parshall (USA), Julian Perry Robinson (UK), and Volker Starrock (Germany). ‡Corresponding author Republication or reproduction of this report or its storage and/or dissemination by electronic means is permitted without the need for formal IUPAC permission on condition that an acknowledgment, with full reference to the source, along with use of the copyright symbol ©, the name IUPAC, and the year of publication, are prominently visible.
    [Show full text]
  • Report on Chemical Munitions Dumped in the Baltic Sea (HELCOM 1994)
    Baltic Sea Environment Proceedings No. 142 Baltic Marine Environment Protection Commission Chemical Munitions Dumped in the Baltic Sea Published by: HELCOM – Baltic Marine Environment Protection Commission Katajanokanlaituri 6 B FI-00160 Helsinki Finland www.helcom.fi Authors: Tobias Knobloch (Dr.), Jacek Bełdowski, Claus Böttcher, Martin Söderström, Niels-Peter Rühl, Jens Sternheim For bibliographic purposes this document should be cited as: HELCOM, 2013 Chemical Munitions Dumped in the Baltic Sea. Report of the ad hoc Expert Group to Update and Review the Existing Information on Dumped Chemical Munitions in the Baltic Sea (HELCOM MUNI) Baltic Sea Environment Proceeding (BSEP) No. 142 Number of pages: 128 Information included in this publication or extracts thereof are free for citation on the condition that the complete reference of the publication is given as stated above Copyright 2013 by the Baltic Marine Environment Protection Commission (HELCOM) ISSN 0357-2994 Language revision: Howard McKee Editing: Minna Pyhälä and Mikhail Durkin Design and layout: Leena Närhi, Bitdesign, Vantaa, Finland Chemical Munitions Dumped in the Baltic Sea Report of the ad hoc Expert Group to Update and Review the Existing Information on Dumped Chemical Munitions in the Baltic Sea (HELCOM MUNI) Table of Contents 1 Executive summary. .5 2 Introduction. .9 2.1 CHEMU report – subjects covered, recommendations & fulfilment. .10 2.2 MUNI report – scope & perspectives. 11 2.3 National and international activities since 1995. .14 2.3.1 Managerial initiatives. .14 2.3.2 Investigations in the Baltic Sea . .23 3 Chemical warfare materials dumped in the Baltic Sea. .28 3.1 Introduction. 29 3.1.1 Dumping activities .
    [Show full text]
  • Critical Care Management of Chemical Exposures 4 the Patients Were Decontaminated Prior to Arriving at the Hospital
    Chapter 4: CRITI C AL CARE MANAGE M ENT OF CHE M I C AL EXPOSURES James Geiling, MD, FCCM Vincent M. Nicolais, MD, FCCM Gregory M. Susla, PharmD, FCCM The views expressed in this article are those of the authors and do not necessarily reflect the position or policy of the Department of Veterans Affairs. Objectives ■ Review measures of preparedness and planning. ■ Describe the purpose of decontamination. ■ Discuss how to evaluate whether a patient has been adequately decontaminated to enter the emergency department (ED), hospital, or intensive care unit (ICU). ■ Summarize the steps necessary to protect hospital staff: decontamination, personal protective equipment (PPE). ■ Review specific agents: diagnosis, identification, and management. If supposedly civilized nations confined their warfare to attacks on the enemy’s troops, the matter of defense against warfare chemicals would be purely a military problem, and therefore beyond the scope of this study. But such is far from the case. In these days of total warfare, the civilians, including women and children, are subject to attack at all times. Colonel Edgar Erskine Hume, Victories of Army Medicine, 1943 Fundamental Disaster Management Case Study A young couple was transported to your hospital’s ED from a local cinema. You have been told there are many others who are being cared for by the emergency medical services and are en route. The 18-year-old male and 17-year-old female were admitted to your ICU after intubation and placement on mechanical ventilation. They are unresponsive and diaphoretic, and they have constricted pupils with excessive lacrimation, vomiting, diarrhea, and restlessness.
    [Show full text]
  • View Document
    Terrorism WHAT CLINICIANS and NEED TO Disaster KNOW Sarin Sponsored for CME Credit by Rush University Medical Center Release Date: April 1, 2005 Expiration Date: March 31, 2007 errorism WHAT T CLINICIANS and NEED TO Disaster KNOW SERIES Uniformed Services University Guest Faculty EDITORS Health Sciences Ronald E. Goans, PhD, MD, MPH* Bethesda, Maryland Clinical Associate Professor Rush University Tulane University School of Public Health & David M. Benedek, MD, LTC, MC, USA Medical Center Tropical Medicine Associate Professor of Psychiatry Chicago, Illinois New Orleans, LA Stephanie R. Black, MD* Steven J. Durning, MD, Maj, USAF, MC* Sunita Hanjura, MD* Assistant Professor of Medicine Associate Professor of Medicine Rockville Internal Medicine Group Section of Infectious Diseases Rockville, MD Department of Internal Medicine Thomas A. Grieger, MD, CAPT, MC, USN* Associate Professor of Psychiatry Niranjan Kanesa-Thasan, MD, MTMH* Daniel Levin, MD* Associate Professor of Military & Director, Medical Affairs & Pharmacovigilance Assistant Professor Emergency Medicine Acambis General Psychiatry Residency Director Assistant Chair of Psychiatry for Graduate Cambridge, MA Department of Psychiatry & Continuing Education Jennifer C. Thompson, MD, MPH, FACP* Gillian S. Gibbs, MPH* Molly J. Hall, MD, Col, USAF, MC, FS* Chief, Department of Clinical Investigation Project Coordinator Assistant Chair & Associate Professor William Beaumont Army Medical Center Center of Excellence for Bioterrorism Department of Psychiatry El Paso, TX Preparedness Derrick Hamaoka, MD, Capt, USAF, MC, FS* Faculty Disclosure Policy Linnea S. Hauge, PhD* Director, Third Year Clerkship It is the policy of the Rush University Medical Educational Specialist Instructor of Psychiatry Department of General Surgery Center Office of Continuing Medical Paul A. Hemmer, MD, MPH, Lt Col, USAF, MC* Education to ensure that its CME activities Associate Professor of Medicine are independent, free of commercial bias AUTHORS and beyond the control of persons or organi- Rush University Benjamin W.
    [Show full text]
  • Toxicological Profile for Acetone Draft for Public Comment
    ACETONE 1 Toxicological Profile for Acetone Draft for Public Comment July 2021 ***DRAFT FOR PUBLIC COMMENT*** ACETONE ii DISCLAIMER Use of trade names is for identification only and does not imply endorsement by the Agency for Toxic Substances and Disease Registry, the Public Health Service, or the U.S. Department of Health and Human Services. This information is distributed solely for the purpose of pre dissemination public comment under applicable information quality guidelines. It has not been formally disseminated by the Agency for Toxic Substances and Disease Registry. It does not represent and should not be construed to represent any agency determination or policy. ***DRAFT FOR PUBLIC COMMENT*** ACETONE iii FOREWORD This toxicological profile is prepared in accordance with guidelines developed by the Agency for Toxic Substances and Disease Registry (ATSDR) and the Environmental Protection Agency (EPA). The original guidelines were published in the Federal Register on April 17, 1987. Each profile will be revised and republished as necessary. The ATSDR toxicological profile succinctly characterizes the toxicologic and adverse health effects information for these toxic substances described therein. Each peer-reviewed profile identifies and reviews the key literature that describes a substance's toxicologic properties. Other pertinent literature is also presented, but is described in less detail than the key studies. The profile is not intended to be an exhaustive document; however, more comprehensive sources of specialty information are referenced. The focus of the profiles is on health and toxicologic information; therefore, each toxicological profile begins with a relevance to public health discussion which would allow a public health professional to make a real-time determination of whether the presence of a particular substance in the environment poses a potential threat to human health.
    [Show full text]
  • Introduction to Emergency Management Second Edition
    Introduction to Emergency Management Second Edition Introduction to Emergency Management Second Edition George D. Haddow Jane A. Bullock With Contributions by Damon P. Coppola Amsterdam • Boston • Heidelberg • London • New York • Oxford • Paris San Diego • San Francisco • Singapore • Sydney • Tokyo Elsevier Butterworth–Heinemann 30 Corporate Drive, Suite 400, Burlington, MA 01803, USA Linacre House, Jordan Hill, Oxford OX2 8DP, UK Copyright © 2006, Elsevier Inc. All rights reserved. No part of this publication may be reproduced, stored in a retrieval system, or transmitted in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise, without the prior written permission of the publisher. Permissions may be sought directly from Elsevier’s Science & Technology Rights Department in Oxford, UK: phone: (+44) 1865 843830, fax: (+44) 1865 853333, e-mail: permissions@elsevier. co.uk. You may also complete your request on-line via the Elsevier homepage (http://elsevier.com), by selecting “Customer Support” and then “Obtaining Permissions.” Recognizing the importance of preserving what has been written, Elsevier prints its books on acid-free paper whenever possible. Library of Congress Cataloging-in-Publication Data Haddow, George D. Introduction to emergency management / George D. Haddow, Jane A. Bullock. — 2nd ed. p. cm. Includes bibliographical references and index. ISBN 0-7506-7961-1 (hardcover : alk. paper) 1. Emergency management. 2. Emergency management—United States. I. Bullock, Jane A. II. Title. HV551.2.H3
    [Show full text]
  • Riot Control Agents? Riot Control Or Incapacitating Agents, Sometimes Referred to As “Tear Gas”, Are a Group of Aerosol-Dispersed Chemical Compounds
    Fact Sheet Riot Control Agents What are Riot Control Agents? Riot control or incapacitating agents, sometimes referred to as “tear gas”, are a group of aerosol-dispersed chemical compounds. These compounds temporarily make people unable to function by causing irritation to the eyes, mouth, throat, lungs and skin. Agents of these types can be dispersed from grenade, bomb, spray or canister and are commonly employed by police and military forces to regain control of crowds. Several different compounds are considered to be riot control agents. The most common compounds are known as: . Chloroacetophenone (CN or Mace7) . Chlorobenzyldenemalononitrile (CS or Tear Gas) For immediate assistance, call . Adamsite (irritating and vomiting agent that acts very the Poison Control Center similarly to CN and CS) Hotline: 1-800-222-1222. Other examples may include: . Oleoresin Capsicum (OC or Pepper Spray) . Chloropicrin (PS), which is also used as a fumigant (uses fumes to disinfect and area) . Bromobenzylcyanide (CA) . Dibenzoxazepine (CR) and combinations of various agents Exposure Riot control agents are used by law enforcement officials for crowd control, and are an effective weapon as they can disable an assailant. Some police SWAT teams have small grenades that contain rubber pellets and/or CS. Riot control agents are also widely used by individuals in the form of pepper spray for personal protection. If exposed, remove clothing, taking care to avoid skin contact with contaminated clothing, and rapidly wash the entire body with soap and water. If the eyes are burning or vision is blurred, rinse eyes out with plain water for 10 to 15 minutes, if wearing contacts remove and place with contaminated clothing.
    [Show full text]
  • Toxidrome Recognition in Chemical- Weapons Attacks
    The new england journal of medicine Review Article Dan L. Longo, M.D., Editor Toxidrome Recognition in Chemical- Weapons Attacks Gregory R. Ciottone, M.D.​​ errorist attacks are increasing in both frequency and com- From Beth Israel Deaconess Medical plexity around the world. In 2016 alone, there were more than 13,400 ter- Center, Harvard Medical School, Boston. 1 Address reprint requests to Dr. Ciottone rorist attacks globally, killing more than 34,000 people. Of equal concern, at Beth Israel Deaconess Medical Center, T Dept. of Emergency Medicine, Rosenberg chemical-warfare agents that were developed for the battlefield are being used on civilians in major cities and conflict zones. The recent sarin attacks in Syria,2,3 the Building, 1 Deaconess Rd., Boston, MA 02215, or at gciotton@ bidmc . harvard . edu. latest in a series of chemical attacks in that region,3,4 along with the use of the nerve agent VX in the assassination of Kim Jong-nam in Malaysia and the Soviet- N Engl J Med 2018;378:1611-20. 5 DOI: 10.1056/NEJMra1705224 era agent Novichok in the poisoning of Sergei Skripal in the United Kingdom, all Copyright © 2018 Massachusetts Medical Society. represent a worrisome trend in the use of deadly chemical agents by various rogue groups in civilian settings. In light of the rise in coordinated, multimodal terrorist attacks in Western urban centers,6,7 concern has been expressed about an increase in the use of chemical agents by terrorists on civilian targets around the world. Such attacks entail unique issues in on-the-scene safety8,9 and also require a rapid medical response.10 As health care providers, we must be proactive in how we prepare for and respond to this new threat.
    [Show full text]
  • 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27
    1 2 3 4 5 UNITED STATES DISTRICT COURT 6 NORTHERN DISTRICT OF CALIFORNIA 7 OAKLAND DIVISION 8 VIETNAM VETERANS OF AMERICA, a Non-Profit Case No. CV 09-0037-CW Corporation; SWORDS TO PLOWSHARES: 9 VETERANS RIGHTS ORGANIZATION, a California Non-Profit Corporation; BRUCE PRICE; FRANKLIN 10 D. ROCHELLE; LARRY MEIROW; ERIC P. MUTH; DAVID C. DUFRANE; WRAY C. FORREST; TIM 11 MICHAEL JOSEPHS; and WILLIAM BLAZINSKI, EXPERT REPORT OF JEFFREY individually, on behalf of themselves and all others D. LASKIN, PH.D. 12 similarly situated, 13 Plaintiffs, 14 vs. 15 CENTRAL INTELLIGENCE AGENCY; DAVID H. PETRAEUS, Director of the Central Intelligence 16 Agency; UNITED STATES DEPARTMENT OF DEFENSE; LEON PANETTA, Secretary of Defense; 17 UNITED STATES DEPARTMENT OF THE ARMY; JOHN MCHUGH, United States Secretary of the 18 Army; UNITED STATES DEPARTMENT OF VETERANS AFFAIRS; and ERIC K. SHINSEKI, 19 UNITED STATES SECRETARY OF VETERANS AFFAIRS, 20 Defendants. 21 22 23 24 25 26 27 28 1 I. INTRODUCTION 2 A. Retention 3 1. I have been retained by Morrison & Foerster LLP on behalf of its clients, plaintiffs 4 in this matter, Vietnam Veterans of America, Swords to Plowshares: Veterans Rights 5 Organization, Bruce Price, Franklin D. Rochelle, Larry Meirow, Eric P. Muth, David C. Dufrane, 6 Wray C. Forrest, Tim Michael Josephs, and William Blazinski (collectively “Plaintiffs”) to serve 7 as a consultant and expert witness in the above captioned action. 8 2. I expect to testify at trial regarding the matters discussed in this expert report, and 9 in any supplemental reports or declarations that I may prepare for this matter.
    [Show full text]
  • Chemical and Biochemical Non-Lethal Weapons Political and Technical Aspects
    SIPRI Policy Paper CHEMICAL AND 23 BIOCHEMICAL November 2008 NON-LETHAL WEAPONS Political and Technical Aspects ronald g. sutherland STOCKHOLM INTERNATIONAL PEACE RESEARCH INSTITUTE SIPRI is an independent international institute for research into problems of peace and conflict, especially those of arms control and disarmament. It was established in 1966 to commemorate Sweden’s 150 years of unbroken peace. The Institute is financed mainly by a grant proposed by the Swedish Government and subsequently approved by the Swedish Parliament. The staff and the Governing Board are international. The Institute also has an Advisory Committee as an international consultative body. The Governing Board is not responsible for the views expressed in the publications of the Institute. GOVERNING BOARD Ambassador Rolf Ekéus, Chairman (Sweden) Dr Willem F. van Eekelen, Vice-Chairman (Netherlands) Dr Alexei G. Arbatov (Russia) Jayantha Dhanapala (Sri Lanka) Dr Nabil Elaraby (Egypt) Rose E. Gottemoeller (United States) Professor Mary Kaldor (United Kingdom) Professor Ronald G. Sutherland (Canada) The Director DIRECTOR Dr Bates Gill (United States) Signalistgatan 9 SE-169 70 Solna, Sweden Telephone: +46 8 655 97 00 Fax: +46 8 655 97 33 Email: [email protected] Internet: www.sipri.org Chemical and Biochemical Non-lethal Weapons Political and Technical Aspects SIPRI Policy Paper No. 23 ronald g. sutherland STOCKHOLM INTERNATIONAL PEACE RESEARCH INSTITUTE November 2008 All substances are poisons; there is none which is not a poison. The right dose differentiates a poison and a remedy. Paracelsus (1493–1541) © SIPRI 2008 All rights reserved. No part of this publication may be reproduced, stored in a retrieval system or transmitted, in any form or by any means, without the prior permission in writing of SIPRI or as expressly permitted by law.
    [Show full text]
  • Medical Management of Chemical Casualties Handbook
    US Army Medical Research Institute of Chemical Defense (USAMRICD) MEDICAL MANAGEMENT OF CHEMICAL CASUALTIES HANDBOOK Chemical Casualty Care Division (MCMR-UV-ZM) USAMRICD 3100 Ricketts Point Road Aberdeen Proving Ground, MD 21010-5400 THIRD EDITION July 2000 Disclaimer The purpose of this Handbook is to provide concise supplemental reading material for attendees of the Medical Management of Chemical Casualties Course. Every effort has been made to make the information contained in this Handbook consistent with official policy and doctrine. This Handbook, however, is not an official Department of the Army publication, nor is it official doctrine. It should not be construed as such unless it is supported by other documents. ii Table of Contents Introduction ................................................................................................................... 1 Pulmonary Agents....................................................................................................... 10 Cyanide ........................................................................................................................ 19 Table. Cyanide (AC and AK). Effects From Vapor Exposure ............................. 25 Vesicants ..................................................................................................................... 30 Mustard..................................................................................................................... 31 Table. Effects of Mustard Vapor ....................................................................................
    [Show full text]
  • Technical Guidance on Special Sites: Chemical Weapons Sites
    Land Contamination: Technical Guidance on Special Sites: Chemical Weapons Sites R&D Technical Report P5-042/TR/02 R Soilleux, J E Steeds & N J Slade Research Contractor: WS Atkins Consultants Limited In association with: DERA Publishing Organisation: Environment Agency Rio House Waterside Drive Aztec West Almondsbury Bristol BS32 4UD Tel: 01454 624400 Fax: 01454 624032 © Environment Agency 2001 ISBN 1 85705 581 0 All rights reserved. No part of this document may be produced, stored in a retrieval system, or transmitted, in any form or by any means, electronic, mechanical, photocopying, recording or otherwise without the prior permission of the Environment Agency. The views expressed in this document are not necessarily those of the Environment Agency, its officers, servant or agents accept no liability whatsoever for any loss or damage arising from the interpretation or use of the information, or reliance upon views contained herein. Dissemination status Internal Status: Released to Regions. External Status: Public Domain. Statement of use This report (P5-042/TR/02) is one of a series providing technical guidance on the complexities and characteristics of Special Sites as defined under the Contaminated Land (England) Regulations 2000 for Part IIA of the Environmental Protection Act 1990. Principally this document is for use by Agency staff carrying out regulatory duties under Part IIA, however this technical guidance contains information that may be of value to other regulators and practitioners dealing with Special Sites. Research contractor This document was produced under R&D Project P5-042 by: WS Atkins Consultants Limited Woodcote Grove Ashley Road Epsom Surrey KT18 5BW Tel: 01372 726140 Fax: 01372 740055 The Environment Agency’s project manager for R&D Project P5-042 was: Phil Humble, Thames Region R&D Technical Report P5-042/TR/02 CONTENTS FOREWORD i GLOSSARY ii 1.
    [Show full text]